185 related articles for article (PubMed ID: 11435242)
1. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis.
Jones TF; Schaffner W
Am J Respir Crit Care Med; 2001 Jul; 164(1):77-81. PubMed ID: 11435242
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
Flaherman VJ; Porco TC; Marseille E; Royce SE
Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
Verma G; Chuck AW; Jacobs P
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
Kowada A; Takasaki J; Kobayashi N
J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees.
Dasgupta K; Menzies D
Eur Respir J; 2005 Jun; 25(6):1107-16. PubMed ID: 15929967
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.
Schwartzman K; Menzies D
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):780-9. PubMed ID: 10712322
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
Oxlade O; Schwartzman K; Menzies D
Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
[TBL] [Abstract][Full Text] [Related]
8. A risk/cost analysis of alternative screening intervals for occupational tuberculosis infection.
Nicas M
Am Ind Hyg Assoc J; 1998 Feb; 59(2):104-12. PubMed ID: 9487664
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
Kowada A
Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
[TBL] [Abstract][Full Text] [Related]
10. Cost-optimisation of screening for latent tuberculosis in close contacts.
Diel R; Nienhaus A; Lange C; Schaberg T
Eur Respir J; 2006 Jul; 28(1):35-44. PubMed ID: 16571615
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis.
Tan M; Menzies D; Schwartzman K
BMC Public Health; 2008 Jun; 8():201. PubMed ID: 18534007
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
Diel R; Wrighton-Smith P; Zellweger JP
Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
[TBL] [Abstract][Full Text] [Related]
13. Direct costs of three models for the screening of latent tuberculosis infection.
Wrighton-Smith P; Zellweger JP
Eur Respir J; 2006 Jul; 28(1):45-50. PubMed ID: 16611659
[TBL] [Abstract][Full Text] [Related]
14. Cost-optimisation of screening for latent tuberculosis in close contacts.
Sadatsafavi M; Najafzadeh M
Eur Respir J; 2006 Dec; 28(6):1285; author reply 1285-6. PubMed ID: 17138688
[No Abstract] [Full Text] [Related]
15. Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation.
Kowada A
Eur J Radiol; 2013 Aug; 82(8):1353-8. PubMed ID: 23489981
[TBL] [Abstract][Full Text] [Related]
16. Assessment of tuberculosis screening and management practices of large jail systems.
Reichard AA; Lobato MN; Roberts CA; Bazerman LB; Hammett TM
Public Health Rep; 2003; 118(6):500-7. PubMed ID: 14563907
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
Diel R; Nienhaus A; Loddenkemper R
Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
[TBL] [Abstract][Full Text] [Related]
18. Tuberculin screening: cost-effectiveness analysis of various testing schedules.
Schechter CB; Rose DN; Fahs MC; Silver AL
Am J Prev Med; 1990; 6(3):167-75. PubMed ID: 2118787
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
[TBL] [Abstract][Full Text] [Related]
20. School-based screening for tuberculous infection. A cost-benefit analysis.
Mohle-Boetani JC; Miller B; Halpern M; Trivedi A; Lessler J; Solomon SL; Fenstersheib M
JAMA; 1995 Aug 23-30; 274(8):613-9. PubMed ID: 7637141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
